Insights

Filters

Updating results

Showing results 1 - 24 of 33 Results per page:

No results found.

Advertising, Marketing & Regulatory
Artificial Intelligence
Automotive
Cannabis
Chemical
Chemical AI
Cleantech
Copyright & Digital Media
Electrical & Computer Technology
Financial Technology
Industrial Designs
IP Management & Strategic Counselling
Licensing & Transactions
Life Sciences
Litigation & Dispute Resolution
Mechanical & Industrial Processes
Medical Technology
Nanotechnology
Oil & Gas
Patents
Plant Breeders’ Rights
Privacy & Data Protection
Psychedelics
Quantum Technologies
Trademarks
Nicholas Aitken
Arvin Angue
Adam Aucoin
William Audet
Ryan Baker
Christie J. C. Bates
Stephen Beney
Brett Benham
Daniel Bereskin
Janice M. Bereskin
Shaivi Bhatt
Adam Bierylo
Paul David Blizzard
Adam Bobker
Jennifer Boothby
Chantalle Briggs
Jonathan G. Burkinshaw
Don Cameron
Isi Caulder
Brigitte Chan
Wynnie Chan
Mina Chana
Herman Cheung
Iris Cheung
Kyle Classen
Toba Cooper
Noel Courage
Carmela De Luca
Ryan De Vries
Reshika Dhir
Meghan Dillon
Terry Edwards
Prudence Ariella Etkin
Michael Fenwick
Patricia Folkins
Cameron Gale
Matthew John Graff
Louis-Pierre Gravelle
Micheline Gravelle
Gail Hung
Nicole Hunter
Jason Hynes
Alissa Hyppolite
Nyrie Israelian
Susan J. Keri
Denis V. Keseris
Ellen Kiernan
Simone Knott
Ray Kovarik
Victor Krichker
Dominique Lambert
François Larose
Julia London
Maddie Lynch
Joanna Ma
R. Scott MacKendrick
Don MacOdrum
Jennifer Manley
Sandra Marone
Andrew McIntosh
Melissa J. McKeon
Ian McMillan
Philip C. Mendes da Costa
Hailey Min
David Morrison
Luba Naiberger
Paige Newman
Andrea Ngo
Tony Orsi
Ainslie Parsons
Chelsea Pham
Justin Philpott
Scott Pundsack
James Raakman
Mohamed Rahal
Bhupinder Randhawa
Sunil Rao
Kimberly Ren
Coralee Ridder
Mark L. Robbins
Jane Sargeant
Timothy Sinnott
Parnian Soltanipanah
Josh Spicer
David St-Martin
Kate Stewart-Tiralongo
Robert Storey
Jessica R. Sudbury
Melanie Szweras
Benjamin Todd
Andrea Uetrecht
Charles Wang
Maria Wei
Tamara Céline Winegust
Shuo Xing
Leanne Young
Jennie Yum
Previous 30 days
Previous 90 days
Previous year
From to

Explore our Insights

January 16, 2023

Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection

By Maddie Lynch and Melanie Szweras

›

December 23, 2022

Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!

By Melanie Szweras and Chantalle Briggs

›

November 16, 2022

USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims

By: Melanie Szweras, Ian McMillan, and Nicole LaBerge

›

November 10, 2022

PMPRB Regulations Saga Coming to an End? New Draft Guidelines Issued

By Nyrie Israelian, Parnian Soltanipanah, Melanie Szweras, Noel Courage

›

September 23, 2022

Class certification for privacy breaches, not so easy to come by

By Melanie Szweras, Parnian Soltanipanah and William Audet

›

July 6, 2022

New front-of-package nutrition symbol requirement for prepackaged foods

By Melanie Szweras and Iris Cheung

›

June 9, 2022

Amendments to the Canadian Patent Rules are coming into force on October 3, 2022

By Melanie Szweras, Patricia Folkins and Dominique Lambert

›

June 2, 2022

Federal Court sets aside Minister of Health’s approval of RUZURGI for the second time over data protection dispute

›

April 27, 2022

Competition Bureau and Health Canada to cooperate to facilitate competition

By Melanie Szweras and Luca Manfredi

›

March 8, 2022

Federal Court Interprets Patent Act Amendments to Prior User Rights Provisions

By Melanie Szweras and Nyrie Israelian

›

February 4, 2022

AI in Focus: Brain-Computer Interface Technologies

By Chantalle Briggs and Melanie Szweras

›

January 25, 2022

2021 Year in Review: Life Sciences

By Melanie Szweras and Alissa Hyppolite

›

November 19, 2021

Federal Court finds Minister of Health’s refusal of BELSOMRA CSP unreasonable, remits for redetermination

By Melanie Szweras and Nyrie Israelian

›

September 23, 2021

Another Positive Outcome for Diagnostic Methods from the Patent Appeal Board

By Melanie Szweras and Parnian Soltanipanah

›

August 11, 2021

Smoothing Out the Patent Prosecution Process for Diagnostic Methods in Canada

By Melanie Szweras and Keon Coleman

›

July 9, 2021

Inducing Infringement by Product Monographs & Skill and Judgment in Medical Use Claims: Key Takeaways from the Federal Court’s decision in Hoffman-La Roche Limited v Sandoz Canada Inc.

By Melanie Szweras, Scott MacKendrick & Maddie Lynch

›

June 2, 2021

Dosage Regimens Affirmed in Canada Again

By Melanie Szweras, Andrea Uetrecht and Madelaine Lynch

›

June 1, 2021

“Comprising” in Claim Construction & Application of the “Obvious to Try” Test: Key Takeaways from the Federal Court’s decision in Merck et al. v Wyeth LLC

By Melanie Szweras, Scott MacKendrick and Nicole LaBerge

›

March 16, 2021

The Federal Court of Appeal Further Clarifies the Test for Obviousness: That Something is “Worth Trying” Does Not Mean That it was Obvious to Try

By Melanie Szweras and Scott MacKendrick

›

February 10, 2021

Life Sciences 2020 Year in Review

By Melanie Szweras and Amy Dam

›

January 20, 2021

Federal Court Invalidates Janssen ZYTIGA® Patent

By Shuo Xing, Melanie Szweras and Scott MacKendrick

›

January 18, 2021

PM(NOC) Invalidity Grounds May Extend Beyond NOA